These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
148 related articles for article (PubMed ID: 31834471)
1. Contemporary application of autologous muscle-derived cells for urinary sphincter regeneration. Kaufman MR World J Urol; 2020 Sep; 38(9):2095-2099. PubMed ID: 31834471 [TBL] [Abstract][Full Text] [Related]
2. A double-blind, randomized, placebo-controlled clinical trial evaluating the safety and efficacy of autologous muscle derived cells in female subjects with stress urinary incontinence. Jankowski RJ; Tu LM; Carlson C; Robert M; Carlson K; Quinlan D; Eisenhardt A; Chen M; Snyder S; Pruchnic R; Chancellor M; Dmochowski R; Kaufman MR; Carr L Int Urol Nephrol; 2018 Dec; 50(12):2153-2165. PubMed ID: 30324580 [TBL] [Abstract][Full Text] [Related]
3. Assessment of the effects of autologous muscle-derived cell injections on urethral sphincter morphometry using 3D/4D ultrasound. Ismail S; Morin M; Tu LM World J Urol; 2020 Nov; 38(11):2881-2889. PubMed ID: 31938840 [TBL] [Abstract][Full Text] [Related]
4. Autologous muscle derived cells for treatment of stress urinary incontinence in women. Peters KM; Dmochowski RR; Carr LK; Robert M; Kaufman MR; Sirls LT; Herschorn S; Birch C; Kultgen PL; Chancellor MB J Urol; 2014 Aug; 192(2):469-76. PubMed ID: 24582537 [TBL] [Abstract][Full Text] [Related]
5. Autologous muscle derived cell therapy for stress urinary incontinence: a prospective, dose ranging study. Carr LK; Robert M; Kultgen PL; Herschorn S; Birch C; Murphy M; Chancellor MB J Urol; 2013 Feb; 189(2):595-601. PubMed ID: 23260547 [TBL] [Abstract][Full Text] [Related]
6. Intraurethral injection of autologous minced skeletal muscle: a simple surgical treatment for stress urinary incontinence. Gräs S; Klarskov N; Lose G J Urol; 2014 Sep; 192(3):850-5. PubMed ID: 24735937 [TBL] [Abstract][Full Text] [Related]
7. Stress urinary incontinence and regenerative medicine: is injecting functional cells into the urethra feasible based on current knowledge and future prospects? Aufderklamm S; Aicher WK; Amend B; Stenzl A Curr Opin Urol; 2019 Jul; 29(4):394-399. PubMed ID: 31033573 [TBL] [Abstract][Full Text] [Related]
8. Applicability of regenerative medicine and tissue engineering for the treatment of stress urinary incontinence in female patients. Zambon JP; Williams KJ; Bennington J; Badlani GH Neurourol Urodyn; 2019 Aug; 38 Suppl 4():S76-S83. PubMed ID: 31099087 [TBL] [Abstract][Full Text] [Related]
9. Regenerative treatment of male stress urinary incontinence by periurethral injection of autologous adipose-derived regenerative cells: 1-year outcomes in 11 patients. Gotoh M; Yamamoto T; Kato M; Majima T; Toriyama K; Kamei Y; Matsukawa Y; Hirakawa A; Funahashi Y Int J Urol; 2014 Mar; 21(3):294-300. PubMed ID: 24033774 [TBL] [Abstract][Full Text] [Related]
10. Autologous Muscle-derived Cell Injection for Treatment of Female Stress Urinary Incontinence: A Single- Arm Clinical Trial with 24-months Follow-Up. Sharifiaghdas F; Zohrabi F; Moghadasali R; Shekarchian S; Jaroughi N; Bolurieh T; Baharvand H; Aghdami N Urol J; 2019 Oct; 16(5):482-487. PubMed ID: 31004339 [TBL] [Abstract][Full Text] [Related]
11. The Midurethral Fascial "Sling on a String": An Alternative to Midurethral Synthetic Tapes in the Era of Mesh Complications. Osman NI; Hillary CJ; Mangera A; Aldamanhoori R; Inman RD; Chapple CR Eur Urol; 2018 Aug; 74(2):191-196. PubMed ID: 29803585 [TBL] [Abstract][Full Text] [Related]
13. Stress urinary incontinence animal models as a tool to study cell-based regenerative therapies targeting the urethral sphincter. Herrera-Imbroda B; Lara MF; Izeta A; Sievert KD; Hart ML Adv Drug Deliv Rev; 2015 Mar; 82-83():106-16. PubMed ID: 25453264 [TBL] [Abstract][Full Text] [Related]
14. Effect of autologous muscle-derived cells in the treatment of urinary incontinence in female patients with intrinsic sphincter deficiency and epispadias: A prospective study. Sharifiaghdas F; Tajalli F; Taheri M; Naji M; Moghadasali R; Aghdami N; Baharvand H; Azimian V; Jaroughi N Int J Urol; 2016 Jul; 23(7):581-6. PubMed ID: 27062371 [TBL] [Abstract][Full Text] [Related]
15. Male synthetic sling versus artificial urinary sphincter trial for men with urodynamic stress incontinence after prostate surgery (MASTER): study protocol for a randomised controlled trial. Constable L; Cotterill N; Cooper D; Glazener C; Drake MJ; Forrest M; Harding C; Kilonzo M; MacLennan G; McCormack K; McDonald A; Mundy A; Norrie J; Pickard R; Ramsay C; Smith R; Wileman S; Abrams P; Trials; 2018 Feb; 19(1):131. PubMed ID: 29467024 [TBL] [Abstract][Full Text] [Related]
16. Muscle-derived cells for treatment of iatrogenic sphincter damage and urinary incontinence in men. Gerullis H; Eimer C; Georgas E; Homburger M; El-Baz AG; Wishahi M; Borós M; Ecke TH; Otto T ScientificWorldJournal; 2012; 2012():898535. PubMed ID: 22919359 [TBL] [Abstract][Full Text] [Related]
17. Ultrasound-guided autologous myoblast injections into the extrinsic urethral sphincter: tissue engineering for the treatment of stress urinary incontinence. Blaganje M; Lukanović A Int Urogynecol J; 2013 Apr; 24(4):533-5. PubMed ID: 23111866 [TBL] [Abstract][Full Text] [Related]
18. State of the art of where we are at using stem cells for stress urinary incontinence. Furuta A; Jankowski RJ; Honda M; Pruchnic R; Yoshimura N; Chancellor MB Neurourol Urodyn; 2007; 26(7):966-71. PubMed ID: 17580339 [TBL] [Abstract][Full Text] [Related]
19. Development of cellular therapy for the treatment of stress urinary incontinence. Wang HJ; Chuang YC; Chancellor MB Int Urogynecol J; 2011 Sep; 22(9):1075-83. PubMed ID: 21505907 [TBL] [Abstract][Full Text] [Related]